Abstract:The morbidity and mortality rates of ischemic stroke (IS) are very high, and IS constitutes one of the main causes of disability and death worldwide. The pathogenesis of ischemic stroke includes excitotoxicity, calcium overload, oxygen radical injury, inflammatory reactions, necrosis/apoptosis, destruction of the blood-brain barrier (BBB), and other pathologic processes. Recent studies have shown that exosomes are critical to the pathogenesis, diagnosis, and treatment of cerebral infarctions resulting from ischemic stroke; and there is growing interest in the role of exosomes and exosomal miRNAs in the diagnosis and treatment of IS. Exosomes from central nervous system cells can be found in cerebrospinal fluid and peripheral bodily fluids, and exosomal contents have been reported to change with disease occurrence. Exosomes are small membranous extracellular vesicles (EVs), 30–150 nm in diameter, that are released from the cell membrane into the depressions that arise from the membranes of multivesicular bodies. Exosomes carry lipids, proteins, mRNAs, and microRNAs (miRNAs) and transport information to target cells. This exosomal transfer of functional mRNAs/miRNAs and proteins ultimately affects transcription and translation within recipient cells. Exosomes are EVs with a double-membrane structure that protects them from ribonucleases in the blood, allowing exosomal miRNAs to be more stable and to avoid degradation. New evidence shows that exosomes derived from neural cells, endothelial cells, and various stem cells create a fertile environment that supports the proliferation and growth of neural cells and endothelial cells, inhibits apoptosis and inflammatory responses, and promotes angiogenesis. In the present review, we discuss how circulating exosomes—and exosomal miRNAs in particular—may provide novel strategies for the early diagnosis and treatment of ischemic stroke via their potential as non-invasive biomarkers and drug carriers.

Considering Context-Specific microRNAs in Ischemic Stroke with Three "W": Where, When, and What

Research Progress of Micro Ribonucleic Acid in Cerebral Ischemia

Using Extracellular Circulating microRNAs to Classify the Etiological Subtypes of Ischemic Stroke

Diagnostic Performance of Circulating MicroRNAs in Acute Ischemic Stroke

Micrornas: Innovative Targets for Cerebral Ischemia and Stroke

Identification of MicroRNAs As Potential Biomarkers for Detecting Ischemic Stroke.

MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic Stroke

MicroRNAs in Cerebral Ischemia.

MicroRNAs and stroke:a brief summary of recent research progress

Diagnostic Performance of Circulating MicroRNAs in Acute Ischemic Stroke A Protocol for Systematic Review and Meta-Analysis

The Diagnostic Value of Circulating Brain-Specific Micrornas for Ischemic Stroke

Characterization of Dysregulated miRNA in Peripheral Blood Mononuclear Cells from Ischemic Stroke Patients

MicroRNAs and stroke

Potential Microrna Biomarkers For Acute Ischemic Stroke

MicroRNA Regulatory Pattern in Diabetic Mouse Cortex at Different Stages Following Ischemic Stroke

Bioinformatics Method Combined with Logistic Regression Analysis Reveal Potentially Important Mirnas in Ischemic Stroke.

Progress of Studies Relevant to the Roles of Micro Ribonucleic Acids in Ischemic Stroke

The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets

Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations

Transcriptome Sequencing Unravels Potential Biomarkers at Different Stages of Cerebral Ischemic Stroke.

MicroRNAs Expression and Function in Cerebral Ischemia Reperfusion Injury